These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28408734)

  • 1. Mycophenolate Mofetil and Pulmonary Fibrosis After Kidney Transplantation: A Case Report.
    Takahashi K; Go P; Stone CH; Safwan M; Putchakayala KG; Kane WJ; Malinzak LE; Kim DY; Denny JE
    Am J Case Rep; 2017 Apr; 18():399-404. PubMed ID: 28408734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sirolimus: a switch option for mycophenolate mofetil-induced leukopenia in renal transplant recipients.
    Shin BC; Chung JH; Kim HL
    Transplant Proc; 2013 Oct; 45(8):2968-9. PubMed ID: 24157014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible chronic pulmonary fibrosis associated with MMF in a pediatric patient: a case report.
    Reynolds BC; Paton JY; Howatson AG; Ramage IJ
    Pediatr Transplant; 2008 Mar; 12(2):228-31. PubMed ID: 18307673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Perioperative agranulocytosis induced by immunosuppressants in a renal graft recipient : a case report].
    Matsumoto K; Kobayashi T; Murakami K; Okubo K; Negoro H; Terada N; Sugino Y; Yamasaki T; Matsui Y; Inoue T; Kamba T; Yoshimura K; Ogawa O
    Hinyokika Kiyo; 2014 Jun; 60(6):275-8. PubMed ID: 25001642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute respiratory failure and pulmonary fibrosis secondary to administration of mycophenolate mofetil.
    Gross DC; Sasaki TM; Buick MK; Light JA
    Transplantation; 1997 Dec; 64(11):1607-9. PubMed ID: 9415567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.
    Feng JJ; Zhang LW; Zhao P; Bow LM; Tian J
    Int J Clin Pract Suppl; 2015 May; (183):1-7. PubMed ID: 26176848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary hemorrhage with capillaritis secondary to mycophenolate mofetil in a heart-transplant patient.
    Gorgan M; Bockorny B; Lawlor M; Volpe J; Fiel-Gan M
    Arch Pathol Lab Med; 2013 Nov; 137(11):1684-7. PubMed ID: 24168511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens.
    Girman P; Lipar K; Koznarova R; Boucek P; Kriz J; Kocik M; Havrdova T; Adamec M; Saudek F
    Transplant Proc; 2010; 42(6):1999-2002. PubMed ID: 20692391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K; Glander P; Krämer BK; Fischer W; Hoffmann U; Bauer S; Grohmann J; Neumayer HH; Arns W
    Transplantation; 2007 Feb; 83(4):417-24. PubMed ID: 17318074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two case reports of successful withdrawal of mycofenolate mofetil after living donor lobar lung transplantation.
    Miyazaki T; Tagawa T; Yamasaki N; Tsuchiya T; Matsumoto K; Nagayasu T
    Transplant Proc; 2013; 45(1):356-9. PubMed ID: 23375323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
    Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
    Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastrointestinal quality of life improvement of renal transplant recipients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium drugs or agents: mycophenolate mofetil and enteric-coated mycophenolate sodium.
    Ortega F; Sánchez-Fructuoso A; Cruzado JM; Gómez-Alamillo JC; Alarcón A; Pallardó L; Morales JM; Oliver J; Guinea G;
    Transplantation; 2011 Aug; 92(4):426-32. PubMed ID: 21760569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive therapy for kidney transplantation in adults: a systematic review and economic model.
    Jones-Hughes T; Snowsill T; Haasova M; Coelho H; Crathorne L; Cooper C; Mujica-Mota R; Peters J; Varley-Campbell J; Huxley N; Moore J; Allwood M; Lowe J; Hyde C; Hoyle M; Bond M; Anderson R
    Health Technol Assess; 2016 Aug; 20(62):1-594. PubMed ID: 27578428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep Ulcers in the Ileum Associated with Mycophenolate Mofetil.
    Sonoda A; Wada K; Mizukami K; Fukuda K; Shuto M; Okamoto K; Ogawa R; Okimoto T; Murakami K
    Intern Med; 2017 Nov; 56(21):2883-2886. PubMed ID: 28943566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus with mycophenolate mofetil or sirolimus compared with calcineurin inhibitor-free immunosuppression (sirolimus/mycophenolate mofetil) after heart transplantation: 5-year results.
    Kaczmarek I; Zaruba MM; Beiras-Fernandez A; Reimann R; Nickel T; Grinninger C; Sadoni S; Hagl C; Meiser B
    J Heart Lung Transplant; 2013 Mar; 32(3):277-84. PubMed ID: 23415313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypogammaglobulinemia and bronchiectasis in mycophenolate mofetil-treated renal transplant recipients: an emerging clinical phenomenon?
    Boddana P; Webb LH; Unsworth J; Brealey M; Bingham C; Harper SJ
    Clin Transplant; 2011; 25(3):417-9. PubMed ID: 20438577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of mycophenolate mofetil on hematological side effects incidence in renal transplant recipients.
    Sobiak J; Kamińska J; Głyda M; Duda G; Chrzanowska M
    Clin Transplant; 2013; 27(4):E407-14. PubMed ID: 23758434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Refractory ascites induced by mycophenolate in a pediatric kidney transplant patient.
    Kim JY; Jang JH; Cho H
    Clin Nephrol; 2021 Apr; 95(4):215-220. PubMed ID: 33560222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.